The tumor of patient 1 revealed the previously detected KRAS p.G12R mutation (frequency: 4.6%), confirmed the NRAS p.Q61R mutation, previously detected using the corresponding antibody (frequency: 3.3%), and revealed an additional NRAS p.G12V mutation (frequency: 7.0%). This evidence concerns the gene NRAS and neoplasm.